Cambridge Investment Research Advisors, Inc. Orgenesis Inc. Call Options Transaction History
Cambridge Investment Research Advisors, Inc.
- $26 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ORGS
# of Institutions
18Shares Held
1.63MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA925KShares$647,5790.0% of portfolio
-
Geode Capital Management, LLC Boston, MA288KShares$201,5680.0% of portfolio
-
Black Rock Inc. New York, NY125KShares$87,6570.0% of portfolio
-
State Street Corp Boston, MA67.7KShares$47,3610.0% of portfolio
-
Ronit Capital LLP54.2KShares$37,9160.1% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $17.9M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...